Abstract
Purpose of Review
Dengue is an important public health problem in many parts of the world. This article consolidates the current knowledge about dengue myocarditis.
Recent Findings
Cardiac involvement in dengue is a common phenomenon. Myocarditis is the predominant manifestation. It can be subclinical with no impact on the outcome, or it can cause potentially fatal arrhythmias or cardiogenic shock and even lead to cardiomyopathy. Myocardial inflammation is elicited by direct viral invasion and production of inflammatory cytokines and free oxygen radicals. The manifestations can overlap with dengue shock syndrome resulting from capillary leakage. The diagnostic criterion is not well-defined and relies on evaluation of cardiac biomarkers and electrocardiographic and echocardiographic changes in the presence or absence of symptoms. There is an emerging role of cardiac magnetic resonance imaging and strain echocardiography. Treatment involves use of supportive therapies, and there is no evidence for use of antiviral drugs, corticosteroids, and immunosuppressants.
Summary
Physicians need to be wary of myocarditis in dengue. More research is needed for developing specific treatment.
Similar content being viewed by others
Code Availability
Not relevant.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Bäck AT, Lundkvist A. Dengue viruses - an overview. Infect Ecol Epidemiol. 2013;30:3. https://doi.org/10.3402/iee.v3i0.19839.
Pothapregada S, Kamalakannan B, Thulasingam M. Clinical profile of atypical manifestations of dengue fever. Indian J Pediatr. 2016;83:493–9. https://doi.org/10.1007/s12098-015-1942-9.
Kirawittaya T, Yoon IK, Wichit S, Green S, Ennis FA, Gibbons RV. Evaluation of cardiac involvement in children with dengue by serial echocardiographic studies. PLoS Negl Trop Dis. 2015;30(9):e0003943. https://doi.org/10.1371/journal.pntd.0003943.
Lakshman A, Balasubramanian P, Nampoothiri RV, Vijayvergiya R, Bhalla A, Varma SC. Elevated cardiac biomarkers and echocardiographic left ventricular dysfunction at admission in patients with dengue fever: report from a tertiary care center in Northwest India. Trop Doct. 2018;48:261–5. https://doi.org/10.1177/0049475518785315.
• Yacoub S, Wertheim H, Simmons CP, Screaton G, Wills B. Cardiovascular manifestations of the emerging dengue pandemic. Nat Rev cardiol. 2014;11:335. https://doi.org/10.1038/nrcardio.2014.40.. (The authors performed an exhaustive review and summarized all the data available till date•)
Biswas S, Kumar P, Tansir G, Biswas A. Case report: Cardiac tamponade in dengue hemorrhagic fever: an unusual manifestation of a common disease. Am J Trop Med Hyg. 2019;101:448–50. https://doi.org/10.4269/ajtmh.19-0153.
Arunachalam N, Murty US, Kabilan L, Balasubramanian A, Thenmozhi V, Narahari D. Studies on dengue in rural areas of Kurnool District, Andhra Pradesh, India. J Am Mosq Control Assoc. 2004;20:87–90.
Balmaseda A, Hammond SN, Pérez MA, Cuadra R, Solano S, Rocha J. Assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg. 2005;73:1059–62. https://doi.org/10.4269/ajtmh.2005.73.1059.
Deen JL, Harris E, Wills B, Balmaseda A, Hammond Rocha SN. The WHO dengue classification and case definitions: time for a reassessment. The Lancet. 2006;8:170–3. https://doi.org/10.1016/S0140-6736(06)69006-5.
Shivanthan MC, Navinan MR, Constantine GR, Rajapakse S. Cardiac involvement in dengue infection. J Infect Dev Ctries. 2015;9:338–46. https://doi.org/10.3855/jidc.6200.
Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(2636–48):2648a–2648d. https://doi.org/10.1093/eurheartj/eht210.
Hober D, Delannoy AS, Benyoucef S, De Groote D, Wattré P. High levels of sTNFR p75 and TNF alpha in dengue-infected patients. Microbiol Immunol. 1996;40:569–73. https://doi.org/10.1111/j.1348-0421.1996.tb01110.x.
Caforio ALP, Malipiero G, Marcolongo R, Iliceto S. Myocarditis A clinical overview. CurrCardiol Rep. 2017;19:63. https://doi.org/10.1007/s11886-017-0870-x.
Salgado DM, Eltit JM, Mansfield K, Panqueba C, Castro D, Vega MR. Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J. 2010;29:238–42. https://doi.org/10.1097/INF.0b013e3181bc3c5b.
Weerakoon KG, Kularatne SA, Edussuriya DH, Kodikara SK, Gunatilake LP, Pinto VG, et al. Histopathological diagnosis of myocarditis in a dengue outbreak in Sri Lanka, 2009. BMC Res Notes. 2011;4:268. https://doi.org/10.1186/1756-0500-4-268.
Obeyesekere I, Hermon Y. Myocarditis and cardiomyopathy after arbovirus infections (dengue and chikungunya fever). Heart. 1972;34:821–7. https://doi.org/10.1136/hrt.34.8.821.
Nagaratnam N, Siripala K, de Silva N. Arbovirus (dengue type) as a cause of acute myocarditis and pericarditis. Br Heart J. 1973;35:204–6. https://doi.org/10.1136/hrt.35.2.204.
Gulati S, Maheshwari A. Atypical manifestations of dengue. Trop Med Int Health. 2007;12:1087–95. https://doi.org/10.1111/j.1365-3156.2007.01891.x.
Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, et al. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation. 2017;136:529–45. https://doi.org/10.1161/CIRCULATIONAHA.117.026386.
Patra S, Bhardwaj G, Manohar JS, Srinivasa KH, Kharge J, Manjunath CN. Acute myocardial infarction being the presentation of dengue myocarditis. J Cardiovasc Dis Res. 2013;4:159–61. https://doi.org/10.1016/j.jcdr.2013.03.001.
Lee CH, Teo C, Low AF. Fulminant dengue myocarditis masquerading as acute myocardial infarction. Int J Cardiol. 2009;136:e69-71. https://doi.org/10.1016/j.ijcard.2008.05.023.
Wali JP, Biswas A, Chandra S, Malhotra A, Aggarwal P, Handa R. Cardiac involvement in dengue haemorrhagic fever. Int J Cardiol. 1998;64:31–6. https://doi.org/10.1016/s0167-5273(98)00008-4.
Kularatne SA, Pathirage MM, Kumarasiri PV, Gunasena S, Mahindawanse SI. Cardiac complications of a dengue fever outbreak in Sri Lanka, 2005. Trans R Soc Trop Med Hyg. 2007;101:804–8. https://doi.org/10.1016/j.trstmh.2007.02.021.
• Satarasinghe RL, Arultnithy K, Amerasena NL, Bulugahapitiya U, Sahayam DV. Asymptomatic myocardial involvement in acute dengue virus infection in a cohort of adult Sri Lankans admitted to a tertiary referral centre. Br J Cardiol. 2007;14:171–3.. (The authors followed up dengue patients without clinical cardiac involvement till 3 months to demonstrate that cardiac lesions were common and completely reversible in their cohort, thus setting the foundation for more similar studies on clinically affected patients•)
Yacoub S, Griffiths A, Chau TT, Simmons CP, Wills B, Hien TT. Cardiac function in Vietnamese patients with different dengue severity grades. Crit Care Med. 2012;40:477–8. https://doi.org/10.1097/CCM.0b013e318232d966.
Miranda CH, Borges MD, Matsuno AK, Vilar FC, Gali LG, Volpe GJ. Evaluation of cardiac involvement during dengue viral infection. Clin Infect Dis. 2013;57:812–9. https://doi.org/10.1093/cid/cit403.
Sengupta SP, Nugurwar A, Jaju R, Khandheria BK. Left ventricular myocardial performance in patients with dengue hemorrhagic fever and thrombocytopenia as assessed by two-dimensional speckle tracking echocardiography. Indian Heart J. 2013;65:276–82. https://doi.org/10.1016/j.ihj.2013.04.017.
• Li Y, Hu Z, Huang Y, Li J, Hong W, Qin Z. Characterization of the Myocarditis during the worst outbreak of dengue infection in China. Medicine. 2016;95:4051. https://doi.org/10.1097/MD.0000000000004051.. (This is the largest study till date and likely gives a better estimate of the incidence of myocarditis•)
Buntubatu S, Prawirohartono EP, Arguni E. Myocarditis prevalence in paediatric dengue infection: a prospective study in tertiary hospital in Yogyakarta, Indonesia. J Trop Pediatr. 2019;65:603–8. https://doi.org/10.1093/tropej/fmz020.
Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr. Myocarditis A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3–14.
Davies MJ, DeWard DE. How can myocarditis be diagnosed and should it be treated? Br Heart J. 1992;68:346–7.
Khongphatthanayothin A, Suesaowalak M, Muangmingsook S, Bhattarakosol P, Pancharoen C. Hemodynamic profiles of patients with dengue hemorrhagic fever during toxic stage: an echocardiographic study. Intensive Care Med. 2003;29:570–4. https://doi.org/10.1007/s00134-003-1671-9.
Wichmann D, Kularatne S, Ehrhardt S, Wijesinghe S, Brattig NW, Abel W, Burchard GD. Cardiac involvement in dengue virus infections during the 2004/2005 dengue fever season in Sri Lanka, Southeast Asian. J Trop Med Public Health. 2009;40:727–30.
Agudelo-Salas IY, Quinceno N, Duque J, Bosch I, Restrepo BN. Actividad en suero de CK y CK-MB en pacientes con infecciónpor el virus dengue [Serum activity of CK and CK-MB in patients with dengue virus infection]. Rev Salud Publica (Bogota). 2017;19:460–7. https://doi.org/10.15446/rsap.v19n4.39597.
Nelson KH, Li T, Afonso L. Diagnostic approach and role of MRI in the assessment of acute myocarditis. Cardiol Rev. 2009;17:24–30. https://doi.org/10.1097/CRD.0b013e318184b383.
Wisotzkey BL, Soriano BD, Albers EL, Ferguson M, Buddhe S. Diagnostic role of strain imaging in atypical myocarditis by echocardiography and cardiac MRI. Pediatr Radiol. 2018;48:835–42. https://doi.org/10.1007/s00247-017-4061-0.
Takano H, Nakagawa K, Ishio N, Daimon M, Daimon M, Kobayashi Y, et al. Active myocarditis in a patient with chronic active Epstein-Barr virus infection. Int J Cardiol. 2008;130:e11–3. https://doi.org/10.1016/j.ijcard.2007.
Kabra SK, Juneja R, Madhulika JY, Singhal T, Dar L. Myocardial dysfunction in children with dengue haemorrhagic fever. Natl Med J India. 1998;11:59–61.
Yadav DK, Choudhary S, Gupta PK, Beniwal MK, Agarwal S, Shukla U. The Tei index and asymptomatic myocarditis in children with severe dengue. PediatrCardiol. 2013;34:1307–13. https://doi.org/10.1007/s00246-013-0639-y.
Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M. Two-dimensional strain–a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr. 2004;17:1021–9. https://doi.org/10.1016/j.echo.2004.06.019.
Bijnens BH, Cikes M, Claus P, Sutherland GR. Velocity and deformation imaging for the assessment of myocardial dysfunction. Eur Echocardiogr. 2009;10:216–26. https://doi.org/10.1093/ejechocard/jen323.
Collier P, Phelan D, Klein A. A test in context: myocardial strain measured by speckle-tracking echocardiography. J Am Coll Cardiol. 2017;69:1043–56. https://doi.org/10.1016/j.jacc.2016.12.012.
Di Bella G, Coglitore S, Zimbalatti C, Minutoli F, Zito C, Patane’ S. Strain Doppler echocardiography can identify longitudinal myocardial dysfunction derived from edema in acute myocarditis. Int J Cardiol. 2008;126:279–80. https://doi.org/10.1016/j.ijcard.2007.01.110.
WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:e240-327. https://doi.org/10.1161/CIR.0b013e31829e8776.
Kishimoto C, Crumpacker CS, Abelmann WH. Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets. J Am Coll Cardiol. 1988;12:1334–41. https://doi.org/10.1016/0735-1097(88)92618-6.
Coletta AP, Clark AL, Cleland JG. Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, beta-interferon study, BACH, and ATHENA. Eur J Heart Fail. 2009;11:214–9. https://doi.org/10.1093/eurjhf/hfn047.
Teysseyre L, Levy Y, Renou A, Vidal C, Larghi M, Biland G, et al. Case report: Refractory shock due to fulminant dengue myocarditis treated with venoarterial extracorporeal membrane oxygenation: a report of four cases. Am J Trop Med Hyg. 2020;104:552–6. https://doi.org/10.4269/ajtmh.20-0372.
Chen HS, Wang W, Wu SN, Liu JP. Corticosteroids for viral myocarditis. Cochrane Database Syst Rev. 2013;10:CD004471. https://doi.org/10.1002/14651858.CD004471.
Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333:269–75. https://doi.org/10.1056/NEJM199508033330501.
Robinson JL, Hartling L, Crumley E, Vandermeer B, Klassen TP. A systematic review of intravenous gamma globulin for therapy of acute myocarditis. BMC Cardiovasc Disord. 2005;5:12. https://doi.org/10.1186/1471-2261-5-12.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Samiksha Gupta, Monica Gupta, Saurabh Gaba, and Gautam Jesrani. The first draft of the manuscript was written by Samiksha Gupta and Saurabh Gaba, and all authors commented on previous versions of the manuscript. The idea for the article was conceived by Monica Gupta. Saurabh Gaba and Gautam Jesrani performed the literature search and data analysis, and Samiksha Gupta, Saurabh Gaba, and Monica Gupta drafted and critically revised the work. All authors read and approved the final manuscript.
As required all authors whose names appear on the submission have (1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; (2) drafted the work or revised it critically for important intellectual content; (3) approved the version to be published; and (4) agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Ethical Approval
Not relevant.
Human and Animal Rights and Informed Consent
This article does not involve and human or animal participants.
Informed Consent From Patient
Not relevant.
Research Involving Human Participants, Their Data, or Biological Material
Not relevant.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Authors’ Declarations
•The manuscript has not been submitted to more than one journal for simultaneous consideration.
•The submitted work is original and has not been published elsewhere in any form or language.
•Results have been presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. The authors have adhered to discipline-specific rules for acquiring, selecting, and processing data.
•No data, text, or theories by others are presented as if they were the authors’ own (“plagiarism”). Proper acknowledgements to other works have been given.
Declaration for Figures and Tables
Permissions for Figures
The article does not contain any figure.
Permissions for Tables
We declare that our tables are original and compiled by us. Therefore, no permissions from any copyright owners are required. Table 3 contains data that has been adequately cited within the table and the cited reference mentioned in the reference section.
This article is part of the Topical Collection on Emerging Tropical Diseases
Rights and permissions
About this article
Cite this article
Gupta, S., Gupta, M., Gaba, S. et al. Insights Into the Emerging Role of Myocarditis in Dengue Fever. Curr Trop Med Rep 8, 239–245 (2021). https://doi.org/10.1007/s40475-021-00249-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40475-021-00249-y